Rocket Pharmaceuticals Inc (NASDAQ:RCKT) shares, rose in value on Thursday, January 02, with the stock price up by 3.82% to the previous day’s close as strong demand from buyers drove the stock to $13.05.
Actively observing the price movement in the recent trading, the stock is buoying the session at $12.57, falling within a range of $12.71 and $13.35. The value of beta (5-year monthly) is 1.089. Referring to stock’s 52-week performance, its high was $31.47, and the low was $11.15. On the whole, RCKT has fluctuated by -9.44% over the past month.
With the market capitalization of Rocket Pharmaceuticals Inc currently standing at about $1.39 billion, investors are eagerly awaiting this quarter’s results, scheduled for in February.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 28.45k.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that RCKT’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of RCKT currently trading nearly 4.84% and -9.26% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 51.32, while the 7-day volatility ratio is showing 5.89% which for the 30-day chart, stands at 6.23%. Furthermore, Rocket Pharmaceuticals Inc (RCKT)’s beta value is 1.00, and its average true range (ATR) is 0.77.
A comparison of Rocket Pharmaceuticals Inc (RCKT) with its peers suggests the former has fared considerably weaker in the market. RCKT showed an intraday change of 3.82% in today’s session so far, and over the past year, it shrunk by -55.76%%.
Data on historical trading for Rocket Pharmaceuticals Inc (NASDAQ:RCKT) indicates that the trading volumes over the past 10 days have averaged 1.78 and over the past 3 months, they’ve averaged 1.12 million. According to company’s latest data on outstanding shares, there are 106.34 million shares outstanding.
Nearly 8.91% of Rocket Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 84.86% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 11.18 million shares as on 2024-12-13, resulting in a short ratio of 8.86. According to the data, the short interest in Rocket Pharmaceuticals Inc (RCKT) stood at 1920.00 of shares outstanding as of 2024-12-13; the number of short shares registered in 2024-11-15 reached 11.09 million. The stock has risen by 3.82% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the RCKT stock heading into the next quarter.
